Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease

H M Farouque; P Sanders; G D Young

doi:10.1016/s0002-9149(00)01219-4

Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease

Am J Cardiol. 2000 Dec 1;86(11):1270-2, A9. doi: 10.1016/s0002-9149(00)01219-4.

Authors

H M Farouque¹, P Sanders, G D Young

Affiliation

¹ The Department of Cardiology, Royal Adelaide Hospital, Australia.

PMID: 11090808
DOI: 10.1016/s0002-9149(00)01219-4

Abstract

The efficacy of intravenous magnesium in terminating sustained monomorphic ventricular tachycardia was examined in this study. This therapy was found to be ineffective in aborting monomorphic ventricular tachycardia induced in the electrophysiology laboratory.

Publication types

Comparative Study

MeSH terms

Anti-Arrhythmia Agents / administration & dosage*
Coronary Disease / complications*
Coronary Disease / physiopathology
Electrocardiography
Female
Heart Rate / drug effects
Humans
Infusions, Intravenous
Magnesium Sulfate / administration & dosage*
Male
Middle Aged
Tachycardia, Ventricular / drug therapy*
Tachycardia, Ventricular / etiology
Tachycardia, Ventricular / physiopathology
Treatment Outcome

Substances

Anti-Arrhythmia Agents
Magnesium Sulfate